HLA‐A, ‐B, and DR Mismatch and Outcomes After Simultaneous Pancreas‐Kidney Transplantation in the Modern Era
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Moksh Sachdeva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. Hauptthemen laut MEDLINE: Pancreas Transplantation, Kidney Transplantation, Graft Rejection, HLA-B Antigens. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council Clinical Research Training Fellowship, Kidney Research UK, National Institute for Health and Care Research (NIHR) Blood and Transplant Research Unit.
Abstract (Originalsprache)
Background
HLA mismatch is known to impact post‐transplant outcomes following kidney‐alone transplantation. However, the impact on kidney outcomes in the context of simultaneous pancreas‐kidney (SPK) transplantation remains uncertain. This study aimed to assess the impact of HLA mismatch on SPK outcomes.
Method
Adult SPK recipients in the UNOS STAR registry (2010–2023) were analysed. Re‐transplants were excluded. Multivariable nonlinear regression models evaluated the impact of HLA mismatch on outcome.
Results
In a cohort of 10,559 SPK recipients overall mismatch was frequent, with only 34 recipients (0.3%) having 0/0/0 mismatches across HLA‐A, HLA‐B, and HLA‐DR. HLA‐DR mismatch was not associated with pancreas or kidney graft survival at 5 years; two versus zero HLA‐DR mismatches aHR = 1.015 (95% CI 0.828–1.243) for pancreas graft survival, and aHR = 0.946 (0.753–1.188) for kidney graft survival. HLA‐DR mismatch was also not associated with pancreas or kidney acute rejection or 12‐month eGFR. HLA‐A and HLA‐B mismatches also showed no association with any pancreas or kidney transplant outcomes. Three‐way interaction analyses between HLA‐A, B and DR demonstrated no evidence that mismatch at any locus affected outcomes, irrespective of mismatch level at the other loci.
Conclusion
In first‐time simultaneous pancreas–kidney transplantation, donor–recipient HLA mismatch was not associated with pancreas or kidney graft survival, rejection, or early renal function. These findings contrast with kidney‐alone transplantation and suggest that classical HLA mismatch effects may be attenuated in the contemporary SPK setting. Prioritising HLA‐based matching, including HLA‐DR, is therefore unlikely to improve short‐ or medium‐term post‐transplant outcomes in first‐time SPK transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
- Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne, UK.
Förderung
- Medical Research Council Clinical Research Training Fellowship
- Kidney Research UK
- National Institute for Health and Care Research (NIHR) Blood and Transplant Research Unit
- Organ Donation and Transplantation
Zitieren
APA
Sachdeva, M., Tingle, S., Kourounis, G., Malik, A., Thompson, E., White, S., Sheerin, N. S., & Wilson, C. (2026). HLA‐A, ‐B, and DR Mismatch and Outcomes After Simultaneous Pancreas‐Kidney Transplantation in the Modern Era. Clinical Transplantation. https://doi.org/10.1111/ctr.70653
Vancouver
Sachdeva M, Tingle S, Kourounis G, Malik A, Thompson E, White S, et al. HLA‐A, ‐B, and DR Mismatch and Outcomes After Simultaneous Pancreas‐Kidney Transplantation in the Modern Era. Clinical Transplantation. 2026. doi:10.1111/ctr.70653
BibTeX
@article{Sachdeva2026,
author = {Sachdeva, Moksh and Tingle, Samuel and Kourounis, Georgios and Malik, Abdullah and Thompson, Emily and White, Steve and Sheerin, Neil S and Wilson, Colin},
title = {HLA‐A, ‐B, and DR Mismatch and Outcomes After Simultaneous Pancreas‐Kidney Transplantation in the Modern Era},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70653}
}
EUVIMED